Emotional and Anxiety Assessments in CNS Disorders





2.

Crawley JN (1981) Neuropharmacologic specificity of a simple animal model for the behavioral actions of benzodiazepines. Pharmacol Biochem Behav 15:695–699PubMedCrossRef


3.

Prut L, Belzung C (2003) The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 463:3–33PubMedCrossRef


4.

File SE, Seth PA (2003) A review of 25 years of the social interaction test. Eur J Pharmacol 463:35–53PubMedCrossRef


5.

Li YF, H Y, Amsdell SL, Xiao L, O’Donnell JM, Zhang HT (2009) Antidepressant- and anxiolytic-like effects of the phosphodiesterase-4 inhibitor rolipram on behavior depend on cyclic amp response element binding protein-mediated neurogenesis in the hippocampus. Neuropsychopharmacology 34:2404–2419PubMedCrossRef


6.

Zhang HT, Huang Y, Masood A, Stolinski LR, Li YF, Zhang L, Dlaboga D, Jin S-LC, Conti M, O’Donnell JM (2007) Anxiogenic-like behavioral phenotype of mice deficient in phosphodiesterase 4B (PDE4B). Neuropsychophar-macology 33:1611–1623PubMedCrossRef
< div class='tao-gold-member'>

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Jul 10, 2016 | Posted by in INTERNAL MEDICINE | Comments Off on Emotional and Anxiety Assessments in CNS Disorders

Full access? Get Clinical Tree

Get Clinical Tree app for offline access